Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

More documents

Recommendations

Info

QUESTIONS KEY WORDS NO.ARTICLESIDENTIFIED9. Does improvedglycaemic controldecrease thedevelopment orprogression ofperipheralneuropathy?Total for Question 9NIDDM/ AND neuropathy.mpAND (glycaemic control.mp ORglycemic control.mp) MNIDDM/bl,mo,nu,cl,pa,co,pc,dh,pp,di,dt,px,rh,ep,et,th AND(CBD/ OR macrovascular.mp ORretinopathy.mp OR neuropathies/OR nephropathy.mp/ OR vasculardisease/ OR coronary disease/ ORdiabetic nephropathies/ OR CVD/OR diabetic microvascular.mp/OR diabetic angiopathies/ ORneuropathy.mp. OR diabeticneuropathy/ OR stroke.mp ORPVD.mp/) LIMIT TO (controlledclinical trial OR clinical trial ORmulticentre study OR RCT ORclinical trial, [phase i – iv] ORmeta analysis) M1720127410NO.RELEVANTARTICLES1654517ARTICLES TOTAL FOR LEVEL I LEVEL II LEVEL LEVEL IV TOTAL NO. HIGHESTIDENTIFIED BY REVIEWIIIREVIEWED & LEVEL OFOTHERSTRATEGIESGRADED EVIDENCE16 45 1 5 6 0 12 IDiabetes mellitus/bl, co, pc, dh,dt, th, et AND (glycemiccontrol.mp OR glycaemiccontrol.mp OR diabetescontrol.mp) AND(neuropathy.mp ORneuropathies.mp OR diabeticneuropathies/) M 99-04Risk factors/ AND diabetic foot/M, CINIDDM/co,dh,pa,dt,pp,ed,ss,ep,et,th AND (glycemic control/ ORdiabetic neuropathies/ OR bloodglucose monitoring/ OR vasculardiseases/ OR neuropathy.mp/ ORdiabetic neuropathies/ OR riskfactors/ OR retinopathy/ OR diet/OR diabetic angiopathies/ ORnephropathy.mp/ OR CVD/ ORretinopathy.mp/ OR glycemiccontrol.mp OR macrovascular.mpOR microvascular.mp ORdiabetes control.mp) CI53264 (M)75(CI)44546 (M)21 (CI)2134
QUESTIONS KEY WORDS NO.ARTICLESIDENTIFIED9. Does improvedglycaemic controldecrease thedevelopment orprogression ofperipheralneuropathy?NIDDM/bl,co,pc,dh,dt,et,th AND(neuropathy.mp ORneuropathies.mp OR diabeticneuropathies/) AND glycaemiccontrol.mp OR glycemiccontrol.mp/ OR diabeticcontrol.mp) CI 99-04(Glycosylated hemoglobin/ ORhemoglobinA1c/ OR HbA1c.mp/)AND Diabetes mellitus/ EM6450NO.RELEVANTARTICLES016ARTICLESIDENTIFIED BYOTHERSTRATEGIESTOTAL FORREVIEWLEVEL I LEVEL II LEVELIIILEVEL IV TOTAL NO.REVIEWED &GRADEDHIGHESTLEVEL OFEVIDENCE(Glycaemic control.mp ORglycaemic control.mp ORdiabetes control/) and NIDDM/AND (peripheral neuropathy/ ORdiabetic neuropathy/ ORneuropathies) EM 99-04716Diabetes mellitus/co,rh,si,epAND Risk factors/ep,co,et,di,pc,si EM50NIDDM.mp AND (glycemiccontrol.mp OR neuropathy.mp)CO174410. Does appropriatefootwear reduceulceration andamputation?Neuropathy.mp AND glycemiccontrol.mp COTotal for Question 10(Orthopedic footwear/ OR shoes/OR footwear.mp) AND skinulcer/ AND diabetes mellitus/ M,CI4198226 (M)15 (CI)52522 (M)1 (CI)53 64 2 4 16 0 22 I(Orthopedic footwear/ OR shoes/OR footwear.mp) AND diabeticfoot/ M, CI221 (M)162 (CI)64 (M)51 (CI)(Orthopedic footwear/ OR shoes/OR footwear.mp) ANDamputation/ M, CI90 (M)67 (CI)10 (M)15 (CI)(Shoe/ OR footwear.mp) ANDskin ulcer/pc,co,rh,di, si,ep,th,etAND diabetes mellitus/co,rh,si,epEM537135
Page 1:
National Evidence Based Guidelinesf
Page 4:
Research OfficersMs Linda SmithPodi
Page 7 and 8:
2.2 Issues for Foot Problems in Typ
Page 9:
• Aim to achieve the best possibl
Page 12 and 13:
Background - Peripheral Neuropathy
Page 14 and 15:
proportion of subjects with a durat
Page 16 and 17:
and an OR 1.1-7.8. This study also
Page 18 and 19:
Summary - Peripheral Neuropathy as
Page 20 and 21:
Section 2: Diabetes Foot ProblemsIs
Page 22 and 23:
predicting risk of amputation, 2.9
Page 24 and 25:
Summary - Peripheral Vascular Disea
Page 26 and 27:
Page 28 and 29:
Evidence - Foot Deformity and Previ
Page 30 and 31:
people with both LJM and neuropathy
Page 32 and 33:
Summary - Foot Deformity and Previo
Page 34 and 35:
Page 36 and 37:
Also in the Seattle study, 67 peopl
Page 38 and 39:
Summary - Ulcer as a Risk Factor fo
Page 40 and 41:
Page 42 and 43:
The other frequently reported metho
Page 44 and 45:
side; and 82% having the same resul
Page 46 and 47:
Evidence Table: Section 5Detection
Page 48 and 49:
Background - Clinical Detection of
Page 50 and 51:
pulse was bilaterally absent in 1.8
Page 52 and 53:
Evidence Table: Section 6AuthorClin
Page 54 and 55:
Background - Frequency of Foot Exam
Page 56 and 57:
Summary - Frequency of Foot Examina
Page 58 and 59:
Page 60 and 61:
Behaviour assessment scores, measur
Page 62 and 63:
Mazzuca et al (1986) studies 532 pe
Page 64 and 65:
with before the programme, after 1-
Page 66 and 67:
Evidence Table: Section 8AuthorEffe
Page 68 and 69:
Background - Glycaemic Control and
Page 70 and 71:
In a previous Japanese randomised s
Page 72 and 73:
Evidence Table: Section 9AuthorGlyc
Page 74 and 75:
Background - Footwear to Reduce Ulc
Page 76 and 77:
period. In addition people without
Page 78 and 79:
Comparisons of in-shoe foot pressur
Page 80 and 81:
The rate of plantar callus formatio
Page 82 and 83:
Evidence Table: Section 10AuthorFoo
Page 84 and 85: Background - Foot Clinics and Multi
Page 86 and 87: A prospective non randomised contro
Page 88 and 89: Summary - Foot Clinics and Multi-di
Page 90 and 91: Section 12: Diabetes Foot ProblemsI
Page 92 and 93: and/or osteomyelitis; III - fore-fo
Page 94 and 95: Summary - Economic consequences•
Page 96 and 97: Section 13: Diabetes Foot ProblemsI
Page 98 and 99: Some ethnic groups are associated w
Page 100 and 101: Evidence Table: Section 13AuthorSoc
Page 102 and 103: Calle-Pascual AL, Duran A, Diaz A,
Page 104 and 105: Jannink MJ, van Dijk H, de Vries J,
Page 106 and 107: Moss SE, Klein R, Klein BE. The 14-
Page 108 and 109: Soulier SM, Godsey C, Asay ED, Perr
Page 110 and 111: Diabetes Foot Problems: General Ref
Page 112 and 113: McNeely MJ, Boyko EJ, Ahroni JH, St
Page 114 and 115: Diabetes Foot Problems: Other Refer
Page 116 and 117: Caputo GM, Cavanagh PR, Ulbrecht JS
Page 118 and 119: Garbalosa JC, Cavanagh PR, Wu G, Ul
Page 120 and 121: Lavery LA, Armstrong DG, Wunderlich
Page 122 and 123: Payne C. Regional variations of dia
Page 124 and 125: Tovi J, Svanborg E, Nilsson BY, Eng
Page 126 and 127: Criteria used to determine the suit
Page 128 and 129: QUESTIONS KEY WORDS NO.ARTICLESIDEN
show all

Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?